Shenzhen YHLO Biotech (SHA:688575) received an in vitro diagnostic medical device certification from the Netherlands' certification agency, BSI Group, for its human immunodeficiency virus or HIV detection kit, according to a Friday disclosure on the Shanghai bourse.
The certificate is valid until Oct. 18, 2026, the in-vitro diagnostic instrument manufacturer said.